← Back to Search

Dietary Tracking App for Amyloidosis (DRITA Trial)

N/A
Recruiting
Led By Jeffrey Zonder, MD
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Diagnosed with any type of amyloidosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 63 days (= 56 days + week 10)
Awards & highlights

DRITA Trial Summary

This trial will study if an app can help understand malnutrition and weight loss in Amyloidosis patients. Participants will use an app to track diet and supplement intake and fill out surveys.

Who is the study for?
This trial is for English-speaking adults over 18 with any type of amyloidosis who are willing to use the MyFitnessPal app on their smartphone. It's not suitable for those with cognitive or perceptual disturbances, or anyone planning a stem cell or organ transplant within 12 weeks after joining.Check my eligibility
What is being tested?
The study tests if it's practical for patients with Amyloidosis to use the MyFitnessPal app to track daily food and supplement intake. Participants will learn how to use the app, record their intake from weeks 2-9, and fill out questionnaires about their experience.See study design
What are the potential side effects?
Since this trial involves using an application rather than medication, there are no direct medical side effects. However, participants may experience inconvenience or privacy concerns related to entering personal dietary information into the app.

DRITA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with amyloidosis.

DRITA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~63 days (= 56 days + week 10)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 63 days (= 56 days + week 10) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence Rate
Secondary outcome measures
Subsequent adherence rate

DRITA Trial Design

1Treatment groups
Experimental Treatment
Group I: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)Experimental Treatment1 Intervention
MyFitnessPal smartphone application is used to track daily dietary intake and herbal/alternative supplements.

Find a Location

Who is running the clinical trial?

Barbara Ann Karmanos Cancer InstituteLead Sponsor
163 Previous Clinical Trials
9,216 Total Patients Enrolled
4 Trials studying Amyloidosis
225 Patients Enrolled for Amyloidosis
Jeffrey Zonder, MDPrincipal InvestigatorBarbara Ann Karmanos Cancer Institute
2 Previous Clinical Trials
83 Total Patients Enrolled
1 Trials studying Amyloidosis
60 Patients Enrolled for Amyloidosis

Media Library

Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) Clinical Trial Eligibility Overview. Trial Name: NCT05738005 — N/A
Amyloidosis Research Study Groups: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Amyloidosis Clinical Trial 2023: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) Highlights & Side Effects. Trial Name: NCT05738005 — N/A
Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05738005 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current capacity for enrolment in this experiment?

"Affirmative. The information available on clinicaltrials.gov evidences that the trial, initially posted on March 2nd 2023, is currently searching for 40 participants across 1 site."

Answered by AI

Are there any available openings in this research study for participants?

"Affirmative. Clinicaltrials.gov records demonstrate that this medical trial, which was initially advertised on March 2nd 2023, is open for recruitment. 40 participants need to be sourced from a single site."

Answered by AI

Who else is applying?

What state do they live in?
Virginia
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
1
Recent research and studies
clinicaltrials.govStudy
Dietary Reporting In The Amyloidoses
Jeffrey Zonder 2023. "Dietary Reporting In The Amyloidoses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05738005.
All > Al Amyloidosis > Amyloidosis
~22 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top